BCL9L Antikörper (AA 397-666)
Kurzübersicht für BCL9L Antikörper (AA 397-666) (ABIN7874649)
Target
Alle BCL9L Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 397-666
-
Verwendungszweck
- BCL9L Antibody
-
Aufreinigung
- Affinity purified
-
Immunogen
- Amino acids E397-A666 from the human protein were used as the immunogen for the BCL9L antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the BCL9L antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store the BCL9L antibody at -20oC.
-
-
- BCL9L (B-Cell CLL/lymphoma 9-Like (BCL9L))
-
Andere Bezeichnung
- BCL9L
-
Hintergrund
- B-cell CLL/lymphoma 9 like is a protein that in humans is encoded by the BCL9L gene. It is mapped to 11q23.3. Bcl-9 (B-cell lymphoma 9, also Protein legless homolog) is a transcriptional regulator that belongs to the Bcl-9 family of proteins. It is expressed in multiple tissues and serves to recruit Pygopus to the Wnt-pathway beta -catenin-TCF complex in the nucleus. Bcl-9 and Bcl-9-2 are considered evolutionary duplicates of Legless that perform the same task with different regulation. Human Bcl-9 is 1426 amino acids (aa) in length. It contains one phosphothreonine and three phosphoserine sites that have been identified so far, two poly-Pro regions (aa 514?517 and 970?973), and one poly-Ala segment (aa 900?903). There is one potential alternate start site at Met27, and a variant isoform exists that shows a four aa substitution for aa 1391?1426. Over aa 1009?1328, human Bcl-9 is 96 % aa identical to mouse Bcl-9.
-
UniProt
- Q86UU0
-
Pathways
- Stem Cell Maintenance
Target
-